AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2005
Aug 16, 2005
34152_dirs_2005-08-16_a812e0db-ba32-4f26-8cf2-7496b7759a3d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-08-12
Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-08-12 | Common Stock, $0.01 Par Value | S | 9500 | $0.705 | Disposed | 11708795 | Indirect |
| 2005-08-15 | Common Stock, $0.01 Par Value | S | 700 | $0.70 | Disposed | 11708095 | Indirect |
| 2005-08-15 | Common Stock, $0.01 Par Value | S | 2500 | $0.71 | Disposed | 11705595 | Indirect |
| 2005-08-15 | Common Stock, $0.01 Par Value | S | 1500 | $0.72 | Disposed | 11704095 | Indirect |
Footnotes
F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23